Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?

We report a patient with metastatic clear-cell renal cell carcinoma (mRCC) who presented with primary tumor in situ in the left kidney and metastases to bone, liver, lungs, and brain. After over 5 years of sunitinib therapy and subsequent cytoreductive left nephrectomy, the patient achieved radiogra...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Amishi Y., Karam, Jose A., Lim, Zita D., Ng, Chaan S., Tannir, Nizar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477704/
https://www.ncbi.nlm.nih.gov/pubmed/26120560
http://dx.doi.org/10.1016/j.eucr.2014.12.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477704/
https://www.ncbi.nlm.nih.gov/pubmed/26120560
http://dx.doi.org/10.1016/j.eucr.2014.12.011

Ejemplares similares